Deputy Chief Physician
Shandong Cancer Hospital and Institute, China (People's Republic)
I am Dr. Lijie Xing, the deputy chief physician of the Department of Hematology, at Shandong Cancer Hospital. In recent years, my research interest is the clinical translational research on multiple myeloma (MM), with a primary focus on preclinical efficacy evaluation of novel drugs for MM and investigating drug resistance mechanisms associated with clinical treatment. Additionally, I have been dedicated to developing innovative combination therapies to overcome drug resistance.